SHERLOCK, a rapid CRISPR-based diagnostic, detects Candida auris and antifungal resistance mutations in patient samples in under an hour.
A new study offers a solution to infections with the pathogenic fungus Candida auris by taking a new precision diagnostic ...
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Sherlock Biosciences, an Engineering Biology company dedicated to making diagnostic testing better, faster and more affordable, today announced that Dr. Martin ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback